Found: 33
Select item for more details and to access through your institution.
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 9, p. 1563, doi. 10.1007/s00432-013-1479-0
- By:
- Publication type:
- Article
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Human Epidermal Growth Factor Receptor 2--Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisornerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. 16, doi. 10.1016/j.clbc.2014.05.004
- By:
- Publication type:
- Article
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 10, p. 1427, doi. 10.3390/jpm13101427
- By:
- Publication type:
- Article
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 8, p. 1280, doi. 10.3390/jpm13081280
- By:
- Publication type:
- Article
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 291, doi. 10.3390/jpm10040291
- By:
- Publication type:
- Article
AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8419, doi. 10.3390/ijms21228419
- By:
- Publication type:
- Article
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221138657
- By:
- Publication type:
- Article
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130142
- By:
- Publication type:
- Article
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2450, doi. 10.3390/cancers15092450
- By:
- Publication type:
- Article
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4571, doi. 10.3390/cancers14194571
- By:
- Publication type:
- Article
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4064, doi. 10.3390/cancers14174064
- By:
- Publication type:
- Article
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092161
- By:
- Publication type:
- Article
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5198, doi. 10.3390/cancers13205198
- By:
- Publication type:
- Article
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 332, doi. 10.3390/cancers13020332
- By:
- Publication type:
- Article
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1525, doi. 10.3390/cancers11101525
- By:
- Publication type:
- Article
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1401, doi. 10.3390/cancers11091401
- By:
- Publication type:
- Article
The obesity paradox in cancer: clinical insights and perspectives.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.651723
- By:
- Publication type:
- Article
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab -paclitaxel for Advanced Pancreatic Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 12, p. 1, doi. 10.3389/fonc.2021.688889
- By:
- Publication type:
- Article
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0325-z
- By:
- Publication type:
- Article
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
- Published in:
- 2023
- By:
- Publication type:
- corrected article
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2313, doi. 10.1002/jcp.26103
- By:
- Publication type:
- Article
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
- By:
- Publication type:
- Article
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00579-2
- By:
- Publication type:
- Article
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 283, doi. 10.1634/theoncologist.2015-0307
- By:
- Publication type:
- Article
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1053035
- By:
- Publication type:
- Article
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7218, doi. 10.3390/curroncol29100569
- By:
- Publication type:
- Article